Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects

被引:67
|
作者
Gill, JMR
Brown, JC
Bedford, D
Wright, DM
Cooney, J
Hughes, DA
Packard, CJ
Caslake, MJ
机构
[1] Univ Glasgow, Dept Vasc Biochem, Glasgow G12 8QQ, Lanark, Scotland
[2] Food Res Inst, Norwich, Norfolk, England
关键词
VLDL; insulin sensitivity; lipoprotein kinetics; liver;
D O I
10.1016/j.atherosclerosis.2004.04.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is probably the defining feature of the metabolic syndrome and is ail important determinant of plasma triglyceride (TG) concentrations. We sought to investigate whether insulin resistance influenced the metabolism of VLDL1 (Sf 60-400) and VLDL2 (Sf 20-60). Sixteen (eight men, eight women) middle-aged, normoglycaemic subjects participated. VLDL1 and VLDL2 apolipoprotein (apo) B metabolism was followed using a deuterated leucine tracer and insulin resistance was estimated using homeostasis model assessment (HOMA). HOMA-estimated insulin resistance (HOMA(IR)) significantly and strongly correlated with the VLDL1 production rate (r = 0.69, P < 0.01) and VLDL1 apo B pool size (r = 0.59, P = 0.02), but these relationships were not evident for VLDL2. Conversely, HOMAIR was not significantly related to the fractional rate of transfer of VLDL1 to VLDL2 but was significantly related to the fractional rate of transfer from VLDL2 to IDL (r = 0.61, P = 0.01). HOMA(IR) was not significantly related to the fractional rate of direct catabolism for either VLDL1 or VLDL2. These results suggest a role for insulin resistance in the determination of hepatic VLDL1 production and highlight the independent regulation of VLDL1 and VLDL2 metabolism. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 50 条
  • [11] Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance
    M. Adiels
    J. Westerbacka
    A. Soro-Paavonen
    A. M. Häkkinen
    S. Vehkavaara
    M. J. Caslake
    C. Packard
    S. O. Olofsson
    H. Yki-Järvinen
    M. R. Taskinen
    J. Borén
    Diabetologia, 2007, 50 : 2356 - 2365
  • [12] Gender Differences in VLDL1 and VLDL2 Triglyceride Kinetics and Fatty Acid Kinetics in Obese Postmenopausal Women and Obese Men
    Sarac, Ivana
    Backhouse, Katharine
    Shojaee-Moradie, Fariba
    Stolinski, Michael
    Robertson, M. Denise
    Bell, Jimmy D.
    Thomas, E. Louise
    Hovorka, Roman
    Wright, John
    Umpleby, A. Margot
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (07): : 2475 - 2481
  • [13] Direct effects of the Asn291Ser variant of the human lipoprotein lipase on the catabolism of VLDL1 and VLDL2 in vivo
    Pietzsch, J
    Julius, U
    Nitzsche, S
    Gehrisch, S
    Leonhardt, W
    Jaross, W
    Hanefeld, M
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 26 - 27
  • [14] Variation in dietary carbohydrate to fat ratio alters distribution of triglyderides in VLDL1 and VLDL2 without altering apolipoprotein B metabolism
    Bisschop, PH
    Ackermans, NT
    De Sain-Van der Velden, MGM
    Barrett, PHR
    Endert, E
    Kuipers, F
    Sauerwein, HP
    Romijn, JA
    DIABETES, 2002, 51 : A599 - A600
  • [15] Differenze di genere nella cinetica dei trigliceridi VLDL1 e VLDL2 e degli acidi grassi in uomini obesi e donne obese in post-menopausaGender differences in VLDL1 and VLDL2 triglyceride kinetics and fatty acid kinetics in obese postmenopausal women and obese men
    I. Sarac
    K. Backhouse
    F. Shojaee-Moradie
    M. Stolinski
    M. D. Robertson
    J. D. Bell
    E. L. Thomas
    R. Hovorka
    J. Wright
    A. M. Umpleby
    Marco Centanni
    Miriam Cellini
    L’Endocrinologo, 2012, 13 (5) : 233 - 233
  • [16] BASELINE APOB-100 AND TRIGLYCERIDE KINETICS PREDICTS POSTPRANDIAL TRIGLYCERIDE AND APOB-48 ACCUMULATION IN CHYLOMICRON, VLDL1 AND VLDL2 FRACTIONS
    Adiels, M.
    Matikainen, N.
    Westerbacka, J.
    Soderlund, S.
    Boren, J.
    Taskinen, M-R
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [17] ALT concentrations within normal range can predict hepatic VLDL1 production
    Al-Shayji, I. A.
    Caslake, M. J.
    Gill, J. M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 23 - 23
  • [18] Endogenous cholesterol synthesis determines the rate of VLDL2 apolipoprotein B100 secretion and not VLDL1 apolipoprotein B100 secretion in humans
    Prinsen, B
    Romijn, JA
    Bisschop, P
    de Barse, M
    Sauerwein, H
    Rabelink, T
    de Sain-van der Velden, M
    CIRCULATION, 2002, 106 (19) : 253 - 253
  • [19] The Role of GLP-2 in Regulation of Hepatic Steatosis and VLDL Production in Insulin Resistance
    Taher, Jennifer
    Baker, Chris
    Adeli, Khosrow
    Naples, Mark
    DIABETES, 2015, 64 : A66 - A66
  • [20] Liraglutide accelerates the catabolism of apolipoprotein B100 containing lipoproteins (VLDL1, VLDL2, IDL and LDL) in patients with type 2 diabetes: an in vivo kinetic study
    Verges, B.
    Bouillet, B.
    Rouland, A.
    Baillot-Rudoni, S.
    Buffier, P.
    Crevisy, E.
    Petit, J.
    Duvillard, L.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S118 - S118